Jonathan Yong
Stock Analyst at UBS
(2.69)
# 1,905
Out of 5,148 analysts
95
Total ratings
62.96%
Success rate
12.32%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Upgrades: Neutral | $12 → $17 | $13.98 | +21.60% | 10 | Jan 9, 2026 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $1.24 | +303.23% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.04 | +47.06% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $13.58 | -11.63% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.17 | +268.66% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $8.83 | +194.45% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $16.48 | -15.05% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $81.37 | +17.98% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $15.00 | +113.33% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $20.40 | +414.71% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $108.06 | -25.97% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $286.47 | -19.36% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $5.16 | +423.26% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $229.88 | -56.50% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $990.95 | -54.59% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $1.14 | +952.63% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $5.30 | +1,220.75% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $22.22 | -23.49% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $152.42 | +129.63% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $23.44 | +305.29% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $1.35 | +529.63% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $24.04 | +70.55% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.39 | +150.74% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $85.65 | -0.76% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $210.25 | -30.56% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $44.60 | +137.67% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $206.42 | -23.94% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $290.85 | +26.53% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $187.28 | +239.06% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $81.66 | +43.28% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $19.57 | +53.30% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $532.92 | -44.08% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $235.12 | -59.60% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $294.93 | +67.84% | 1 | Oct 15, 2021 |
Oscar Health
Jan 9, 2026
Upgrades: Neutral
Price Target: $12 → $17
Current: $13.98
Upside: +21.60%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $1.24
Upside: +303.23%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.04
Upside: +47.06%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $13.58
Upside: -11.63%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.17
Upside: +268.66%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $8.83
Upside: +194.45%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $16.48
Upside: -15.05%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $81.37
Upside: +17.98%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.00
Upside: +113.33%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $20.40
Upside: +414.71%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $108.06
Upside: -25.97%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $286.47
Upside: -19.36%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $5.16
Upside: +423.26%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $229.88
Upside: -56.50%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $990.95
Upside: -54.59%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $1.14
Upside: +952.63%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $5.30
Upside: +1,220.75%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $22.22
Upside: -23.49%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $152.42
Upside: +129.63%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $23.44
Upside: +305.29%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $1.35
Upside: +529.63%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $24.04
Upside: +70.55%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.39
Upside: +150.74%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $85.65
Upside: -0.76%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $210.25
Upside: -30.56%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $44.60
Upside: +137.67%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $206.42
Upside: -23.94%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $290.85
Upside: +26.53%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $187.28
Upside: +239.06%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $81.66
Upside: +43.28%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $19.57
Upside: +53.30%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $532.92
Upside: -44.08%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $235.12
Upside: -59.60%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $294.93
Upside: +67.84%